Issues and Events

The 2025 Clinical Update Conference will be held at the Omni Orlando Resort at ChampionsGate in Orlando, Florida, from 31 January to 2 February. This conference is designed for health care professionals who provide clinical care and education for people with diabetes. For more information, please visit professional.diabetes.org/clinical-update-conference.

The 85th annual American Diabetes Association (ADA) Scientific Sessions will be held in Chicago, Illinois, 20–23 June 2025, at the McCormick Place Convention Center. Abstract submission is now open. The committee encourages submissions that are innovative, challenge current treatment paradigms, and represent the latest advances in basic, clinical, and translational science. The submission deadline is 6 January 2025. For more information, please visit professional.diabetes.org/scientific-sessions.

This special collection of articles published in the December issue of Diabetes Care focuses on the Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) study, which examines the effects of early diagnosis and intervention for women with gestational diabetes mellitus (GDM) detected during their initial prenatal visits. The collection explores whether early treatment can lead to better maternal and neonatal outcomes compared with standard practices. These articles provide key insights into improving care for women with GDM and reducing the risk of complications for both mother and child. To access the collection, visit diabetesjournals.org/collection/2624/TOBOGM-Study.

With the advent of newer, more effective therapies, interest is growing in the clinical management of obesity. A new Diabetes Spectrum From Research to Practice section reviews the rapidly changing landscape of obesity medicine, with a focus on the expanding armamentarium of pharmacotherapies. Articles in this timely collection review current treatment guidelines, first-generation medications that still play an important role, game-changing second-generation drugs from the glucagon-like peptide 1 receptor agonist class, and the use of obesity drugs in the pediatric population. To access the special collection, as well as the full issue, visit diabetesjournals.org/spectrum.

Diabetes is a prevalent chronic disease in school-age children. To keep students with diabetes safe at school, support their long-term health, prevent complications, and ensure full participation in all school activities, proper monitoring of and response to glucose levels must be attended to throughout the school day and during all school-sponsored activities. In this ADA statement, the authors review the legal framework for diabetes care in schools, the core components of school-based diabetes care, the responsibilities of various stakeholders, and special circumstances. The article can be accessed at doi.org/10.2337/dci24-0082.

In a special series, Dr. Neil Skolnik explores the crucial connection between oral health and diabetes management. In the second episode of the series, Dr. Skolnik continues his conversation with Dr. Wenche Borgnakke. Together, they cover practical tips for clinicians to share with patients about oral health. In partnership with Haleon, the ADA aims to create better collaboration between dentists and primary care doctors to improve patient outcomes. For more information, please visit diabetesjournals.org/journals/pages/oral_health_and_diabetes_podcasts.